Medical News

RSS

Researchers find Fountain of Youth while conducting breast cancer research

The Fountain of Youth has been discovered and it's not in Florida as Ponce de Leon claimed. Instead, it was found in the mammary glands of genetically modified mice.

9 Apr 2015

New study describes economic consequences of using T2Candida Panel for detection of candidemia

A new study describes a model that estimates the economic consequences of using the T2Candida Panel (a novel diagnostic product that provides Candida detection) as an adjunct to the current blood culture-based diagnostic strategy in a high-risk hospital patient cohort.

9 Apr 2015

Plymouth researchers receive grant to develop effective therapy for Huntington's disease

Huntington's disease is an hereditary disorder of the nervous system caused by a faulty gene on chromosome four. The faulty gene leads to nerve damage in the area of the brain resulting in gradual physical, mental and emotional changes. Those born to a parent with Huntington's disease have a 50:50 chance of developing it, and there is currently no cure.

9 Apr 2015

Diet rich in high glucoraphanin broccoli reduces blood LDL-cholesterol levels by around 6%

Including a new broccoli variety in the diet reduces blood LDL-cholesterol levels by around 6%, according to the results of human trials led by the Institute of Food Research.

9 Apr 2015

TABS study: Older people can improve their health by reducing sitting time

"I feel lethargic when I sit all day," said Gerald Alexander, an 82-year-old retired social service worker among the 25 Group Health patients who participated in the Take Active Breaks from Sitting (TABS) pilot study. "I feel much peppier when I stand and take walks."

9 Apr 2015

Understanding emotional processing deficit

Kessler Foundation researchers have linked the inability to recognize facial affect (emotion) with white matter damage after traumatic brain injury (TBI), an important first step toward understanding this emotional processing deficit. Their findings indicate a pattern of white matter damage and gray matter atrophy associated with this specific impairment of social cognition after TBI.

9 Apr 2015

UL researchers awarded €250,000 to develop assistive exoskeletons for older adults

Researchers at the Design Factors Research Group at the University of Limerick have been awarded €250,000 funding to develop an exoskeleton to assist older adults. The research will be carried out as part of the AXO-SUIT project, which will run for 3 years with a total budget of almost €3 million. UL will partner with Cork based company MTD Ltd in the design and manufacture of the concept.

9 Apr 2015

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Mobidiag Ltd, a Finnish molecular diagnostics company specialized in the development of innovative diagnostics solutions for infectious diseases, today announced the launch of Amplidiag C. difficile+027, a qualitative qPCR-based test performed from DNA extracted from stool in suspected cases of C. difficile infection (CDI).

9 Apr 2015

Johns Hopkins neurosurgeon awarded Cortes de Cadiz Prize by the city council of Cadiz, Spain

Johns Hopkins neurosurgeon Alfredo Quinones-Hinojosa has been awarded the Cortes de Cadiz Prize in the category of surgery by the city council of Cadiz, Spain. The jury prize, in which members of the Royal Academy of Medicine and Surgery took part, was awarded to Quinones-Hinojosa not only for his renowned scientific career but also for his “moving life experience,” which, the judges noted, is full of “self-improvement and success.”

9 Apr 2015

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 (“miR-103/107”) for the treatment of Non Alcoholic Steatohepatitis (“NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies’ strategic alliance to discover, develop and commercialize microRNA therapeutics.

9 Apr 2015

Countdown begins for 10th BIOVISION forum

The countdown begins with only one week to go until the life science event of the year. The BIOVISION forum is now in it’s 10th year, hosting over 1,500 attendees from the international health care and life sciences sector.

9 Apr 2015

Short-term balance program can reduce risk of falling in older population

Falling is bad news for senior citizens—oftentimes resulting in life-changing injuries, such as hip fractures and head traumas, and an increased risk of early death. New research findings at University of the Sciences into how and why seniors fall may provide healthcare providers with insight on improved balance and strength-training strategies to prevent tumbles by the elderly.

8 Apr 2015

Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Jersey Shore has earned The Joint Commission's Gold Seal of Approval for its Hip and Knee Joint Replacement Program by demonstrating compliance with The Joint Commission's national standards for health care quality and safety in disease-specific care. The certification award recognizes the hospital's dedication to continuous compliance with The Joint Commission's rigorous standards.

8 Apr 2015

$Incidence, costs of osteoporotic fractures in China to double by 2035$

Incidence, costs of osteoporotic fractures in China to double by 2035

The results of the first study using a health economics model to project osteoporosis-related fractures and costs for the Chinese population, shows that the country's healthcare system will face a dramatic rise in costs over the next few decades.

8 Apr 2015

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year.

8 Apr 2015

Phase 1 clinical trial: Anti-HIV antibody significantly decreases HIV levels

A single infusion of an experimental anti-HIV antibody called 3BNC117 resulted in significantly decreased HIV levels that persisted for as long as 28 days in HIV-infected individuals, according to Phase 1 clinical trial findings published online today in Nature.

8 Apr 2015

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Patients hospitalized with advanced cirrhosis, a chronic and degenerative disease of the liver, are at increased risk of death. The tools currently used to assess that risk are limited in predicting which patients will need a liver transplant and which will be healthy enough to survive transplantation.

8 Apr 2015

Changes in height can affect risk of coronary heart disease

The shorter you are- the more your risk of coronary heart disease. That's the key finding of a new study led by the University of Leicester which discovered that every 2.5 inches change in your height affected your risk of coronary heart disease by 13.5%. For example, compared to a 5ft 6inch tall person, a 5 foot tall person on average has a 32% higher risk of coronary heart disease because of their relatively shorter stature.

8 Apr 2015

Public Health Agency of Canada issues statement on measles

The Public Health Agency of Canada is again reminding Canadians of the importance of ensuring their immunizations are up to date, following the confirmation of additional cases of measles in the Vancouver region.

8 Apr 2015

Frost & Sullivan forecasts growth of global healthcare market

The healthcare industry is entangled in a transitory phase in which therapeutics, devices, products and services are sold into traditional care settings that are unable to keep up with the requirements placed upon it by changing demographics and consumer needs. At the same time, opportunities for new services and care, such as ambulatory, mobile, and home care, lack the appropriate level of maturity to provide robust revenue streams despite having the promise to increase healthcare delivery efficiency and reduce long term costs.

8 Apr 2015

Medical News

Researchers find Fountain of Youth while conducting breast cancer research

New study describes economic consequences of using T2Candida Panel for detection of candidemia

Plymouth researchers receive grant to develop effective therapy for Huntington's disease

Diet rich in high glucoraphanin broccoli reduces blood LDL-cholesterol levels by around 6%

TABS study: Older people can improve their health by reducing sitting time

Understanding emotional processing deficit

UL researchers awarded €250,000 to develop assistive exoskeletons for older adults

Mobidiag announces CE-IVD marking and launching of Amplidiag C. difficile+027 test

Johns Hopkins neurosurgeon awarded Cortes de Cadiz Prize by the city council of Cadiz, Spain

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Countdown begins for 10th BIOVISION forum

Short-term balance program can reduce risk of falling in older population

Jersey Shore achieves Joint Commission certification for Hip and Knee Joint Replacement Program

Incidence, costs of osteoporotic fractures in China to double by 2035

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

Phase 1 clinical trial: Anti-HIV antibody significantly decreases HIV levels

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Changes in height can affect risk of coronary heart disease

Public Health Agency of Canada issues statement on measles

Frost & Sullivan forecasts growth of global healthcare market

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News